Text Size
Drug
Search

Shopping
Cart
Sub Total : $0.00
Place your mouse over each cart item to see full description.
             

Chemical Name: Riluzole

Please select Dosage and Quantity
  Product Manufacturer Country Dosage Quantity Price($USD)    
Rilutek  Sanofi Aventis Australia 50 mg 56 $455.00
Rilutek  Aventis Turkey 50 mg 56 $399.00
Rilutek  Sanofi Aventis Canada 50 mg 60 $759.00
Rilutek  Aventis Turkey 50 mg 112 $789.00
Riluzole  Generic United Kingdom 50 mg 56 $149.00
Riluzole  Generic Canada 50 mg 60 $393.00
Riluzole  Generic United Kingdom 50 mg 112 $249.00
Riluzole  Generic Canada 50 mg 120 $775.00
Riluzole  Generic United Kingdom 50 mg 168 $349.00

Rilutek Information:

RILUTEK (Riluzole) is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS). Clinical trials have demonstrated that RILUTEK (Riluzole) extends survival for patients with ALS. Survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free. There is no evidence that RILUTEK (Riluzole) exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms. RILUTEK (Riluzole) has not been shown to be effective in the late stages of ALS. Safety and efficacy of RILUTEK (Riluzole) has only been studied in ALS. Therefore, RILUTEK (Riluzole) should not be used in patients with any other form of motor neurone disease.

Rilutek Side Effects:

SIDE EFFECTS, that may go away during treatment, include nausea, vomiting, stomachache, dizziness, diarrhea, sleepiness, or weakness. If they continue or are bothersome, check with your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience difficulty breathing or fever. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.

Treatment with riluzole should only be initiated by specialist physicians with experience in the management of motor neurone diseases. The recommended daily dose in adults or elderly is 100 mg (50 mg every 12 hours). No significant increased benefit can be expected from higher daily doses. Special populations: Children: RILUTEK is not recommended for use in children, as the safety and effectiveness of riluzole in any neurodegenerative disease occurring in children or adolescents have not been established (see 4.4. Special Warnings and Special Precautions for Use). Patients with Impaired Renal Function: RILUTEK is not recommended for use in patients with impaired renal function, as studies at repeated doses have not been conducted in this population. Elderly:Based on pharmacokinetic data, there are no special instructions for the use of RILUTEK in this population.

The generic alternative is not manufactured by the company that makes the brand product.

All prices are in US dollars.

The content on this page has been supplied to MediSave.ca by an independent third party contracted to provide information for our website. MediSave.ca relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, India, and United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.

Back to Main Drug Information Page